InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 22.01
-0.29 (-1.30%)
At close: Feb 13, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 12.73 billion as of February 13, 2026. Its market cap has increased by 64.46% in one year.
Market Cap
12.73B
Enterprise Value
11.22B
Revenue
180.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.01
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 12.73B, an increase of 44.79%. That is a compound annual growth rate of 10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 12.73B | -19.20% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 14.55B |
| Tibet Cheezheng Tibetan Medicine | 13.91B |
| Pacific Shuanglin Bio-pharmacy | 12.82B |
| Hualan Biological Vaccine | 12.48B |
| Staidson (Beijing) BioPharmaceuticals | 12.46B |
| Beijing Hotgen Biotech | 12.15B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.83B |
| HitGen | 11.76B |